文献速递脑血管病

甘珀酸经多巴胺D2受体调节缺血后炎症反应

Carbenoxolone Modulates Dopamine D2 Receptor–Associated Inflammatory Responses After Ischemic Stress
RSS 订阅 · Stroke

该研究在大鼠脑缺血再灌注模型及体外氧糖剥夺/复氧模型中,探讨甘珀酸是否通过星形胶质细胞Drd2信号调节反应性星形胶质细胞表型。结果显示甘珀酸减少梗死体积、改善神经功能,并减轻炎症信号和反应性星形胶质细胞标志物表达,Drd2敲低部分削弱其细胞保护作用。

要点

  • 甘珀酸减少大鼠脑缺血再灌注后梗死体积并改善神经功能。
  • 甘珀酸下调星形胶质细胞炎症信号及反应性标志物如IL-1β和CD44。
  • Drd2敲低部分削弱甘珀酸在氧糖剥夺/复氧后的细胞保护作用。

核心结论

  • 甘珀酸调节缺血后炎症反应和反应性星形胶质细胞相关程序,Drd2信号参与介导其神经保护作用。

研究设计与样本

  • 采用大鼠脑缺血再灌注体内模型及体外氧糖剥夺/复氧模型,结合RNA测序、qRT-PCR、Western blot和Drd2基因敲低方法。

主要发现

  • 甘珀酸在急性期和缺血再灌注后14天均减少大鼠梗死体积并改善神经功能。
  • RNA测序显示甘珀酸减弱炎症信号并降低反应性星形胶质细胞标志物白细胞介素-1β和Cd44表达。
  • RNA测序发现甘珀酸处理大鼠中Drd2为显著上调基因,并经mRNA和蛋白水平验证。
  • 氧糖剥夺/复氧下甘珀酸提高星形胶质细胞及神经元-星形胶质细胞共培养存活,但不提高单独神经元存活。
  • Drd2基因沉默在基础条件下增加反应性星形胶质细胞标志物Cd44,并部分削弱甘珀酸诱导的细胞保护。

临床怎么用

  • 提示Drd2信号可能作为缺血性脑损伤的潜在治疗靶点,甘珀酸相关神经保护机制涉及星形胶质细胞介导的炎症调节。

局限性

  • 原文未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Stroke, Ahead of Print. BACKGROUND:Despite advances in reperfusion therapy, ischemic brain injury remains a major cause of disability. Astrocytes play a central role in postischemic inflammation and tissue remodeling, but the molecular drivers of their reactive state transitions remain unclear. Here, we investigated whether carbenoxolone modulates reactive astrocyte phenotypes through astrocyticDrd2signaling after cerebral ischemia.METHODS:In vivo rat cerebral ischemia–reperfusion model and in vitro oxygen-glucose deprivation/reperfusion paradigms were used. Infarct volume and neurological outcomes were assessed in vivo. Transcriptomic profiling was performed by RNA sequencing, followed by validation of representative genes using quantitative real-time polymerase chain reaction. Functional effects were evaluated in astrocytes and neuron-astrocyte coculture systems, and the involvement ofDrd2was examined using genetic knockdown approaches.RESULTS:Carbenoxolone reduced infarct volume and improved neurological outcomes both in the acute phase and 14 days after cerebral ischemia–reperfusion in rats. RNA sequencing revealed that carbenoxolone attenuated inflammatory signaling and reduced the expression of reactive astrocyte markers, including interleukin-1 beta andCd44. RNA sequencing identifiedDrd2as a prominently upregulated gene in carbenoxolone-treated rats compared with saline controls. These transcriptional changes were validated at both the mRNA level by quantitative real-time polymerase chain reaction and the protein level by Western blotting. Functionally, under oxygen-glucose deprivation/reperfusion conditions, carbenoxolone enhanced cell survival in astrocytes and neuron–astrocyte cocultures, but not in neurons alone, indicating an astrocyte-mediated protective effect. Genetic silencing ofDrd2increased the reactive astrocyte marker Cd44 (cluster of differentiation 44) under basal conditions and partially attenuated carbenoxolone-induced cytoprotection after oxygen-glucose deprivation/reperfusion.CONCLUSIONS:Carbenoxolone modulates postischemic inflammatory responses and reactive astrocyte-associated programs, with evidence supporting a role forDrd2signaling in these effects. These findings provide mechanistic insight into carbenoxolone-mediated neuroprotection and suggestDrd2signaling as a potential therapeutic target in ischemic brain injury.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Stroke:Carbenoxolone Modulates Dopamine D2 Receptor–Associated Inflammatory Responses After Ischemic Stress

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。